X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (40) 40
humans (36) 36
pharmacology & pharmacy (29) 29
carbonyl reductase (23) 23
animals (21) 21
alcohol oxidoreductases - metabolism (19) 19
enzymes (17) 17
cancer (15) 15
toxicology (14) 14
metabolism (13) 13
physiological aspects (13) 13
alcohol oxidoreductases - genetics (12) 12
anthracyclines (11) 11
carbonyls (10) 10
liver - enzymology (10) 10
aldo-keto reductases (9) 9
biochemistry & molecular biology (9) 9
female (9) 9
gene expression (9) 9
in-vitro (9) 9
kinetics (9) 9
male (9) 9
metabolites (9) 9
pharmacokinetics (9) 9
proteins (9) 9
aldehyde reductase (8) 8
aldo-keto reductase (8) 8
carbonyl reduction (8) 8
liver (8) 8
doxorubicin (7) 7
drug metabolism (7) 7
in-vitro metabolism (7) 7
microsomes, liver - enzymology (7) 7
oxidation-reduction (7) 7
rats (7) 7
short-chain dehydrogenase/reductase (7) 7
substrate specificity (7) 7
11-beta-hydroxysteroid dehydrogenase type-1 (6) 6
anthracycline (6) 6
biochemistry (6) 6
biotransformation (6) 6
cell line, tumor (6) 6
chemotherapy (6) 6
expression (6) 6
genotype (6) 6
liver - drug effects (6) 6
oncology (6) 6
pharmacogenetics (6) 6
reductase (6) 6
reductases (6) 6
acute myeloid-leukemia (5) 5
alcohol oxidoreductases - chemistry (5) 5
article (5) 5
carbonyl reductase 1 (5) 5
cardiotoxicity (5) 5
dehydrogenases (5) 5
human liver (5) 5
human liver cytosol (5) 5
induction (5) 5
oxidative stress (5) 5
pharmacy (5) 5
research article (5) 5
acid (4) 4
alcohol oxidoreductases - antagonists & inhibitors (4) 4
aldo-keto reductase family 1 member c3 (4) 4
analysis (4) 4
biology (4) 4
catalysis (4) 4
chemistry, multidisciplinary (4) 4
cytochrome p-450 (4) 4
cytosol - enzymology (4) 4
daunorubicin (4) 4
dehydrogenase (4) 4
doxorubicin - metabolism (4) 4
doxorubicin - pharmacokinetics (4) 4
drug resistance, neoplasm (4) 4
drugs (4) 4
enzyme inhibitors - pharmacology (4) 4
genes (4) 4
genomics (4) 4
medicine (4) 4
oxidoreductases - metabolism (4) 4
performance liquid-chromatography (4) 4
polymorphism (4) 4
polymorphism, genetic (4) 4
purification (4) 4
research (4) 4
resistance (4) 4
rna, messenger - metabolism (4) 4
science (4) 4
xenobiotics (4) 4
xenobiotics - metabolism (4) 4
11-beta-hydroxysteroid dehydrogenases - metabolism (3) 3
20-hydroxysteroid dehydrogenases - genetics (3) 3
3-hydroxysteroid dehydrogenases - genetics (3) 3
3-hydroxysteroid dehydrogenases - metabolism (3) 3
adult (3) 3
aged (3) 3
alcohol-dehydrogenase (3) 3
aldehyde reductase - genetics (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 06/2013, Volume 75, Issue 6, pp. 1497 - 1505
Aims Aldo-ketoreductases have been implicated in the metabolism of doxorubicin. We sought to assess the influence of AKR1C3 genetic variants on doxorubicin... 
carbonyl reductase (CBR)3 | solute carrier family | ATP‐binding cassette (ABCB)1 | aldo‐ketoreductase (AKR)1C3 | doxorubicin | (SLC)22A16 | pharmacogenetics | Aldo-ketoreductase (AKR)1C3 | Carbonyl reductase (CBR)3 | Pharmacogenetics | ATP-binding cassette (ABCB)1 | Doxorubicin | Solute carrier family (SLC)22A16 | KETO REDUCTASES | CYCLOPHOSPHAMIDE | solute carrier family (SLC)22A16 | TOXICITY | aldo-ketoreductase (AKR)1C3 | DISPOSITION | POLYMORPHISMS | PHARMACOKINETICS | ANTHRACYCLINE-INDUCED CARDIOTOXICITY | PHARMACOLOGY & PHARMACY | EXPRESSION | EXPOSURE | Multivariate Analysis | Humans | Middle Aged | Asian Continental Ancestry Group - genetics | Genotyping Techniques | Breast Neoplasms - metabolism | Alcohol Oxidoreductases - genetics | Adult | Female | Antibiotics, Antineoplastic - pharmacokinetics | Exons - genetics | Genotype | Breast Neoplasms - drug therapy | Doxorubicin - pharmacokinetics | Hydroxyprostaglandin Dehydrogenases - genetics | Disease-Free Survival | Breast Neoplasms - genetics | ATP-Binding Cassette, Sub-Family B, Member 1 - genetics | Aldo-Keto Reductase Family 1 Member C3 | ATP Binding Cassette Transporter, Sub-Family B | Aged | Polymorphism, Single Nucleotide | 3-Hydroxysteroid Dehydrogenases - genetics | Organic Cation Transport Proteins - genetics | Care and treatment | Anthracyclines | Chemotherapy | Analysis | Physiological aspects | Breast cancer | Cancer | Index Medicus
Journal Article
Progress in Lipid Research, ISSN 0163-7827, 01/2016, Volume 61, pp. 149 - 162
The nuclear receptor peroxisome proliferator-activated receptor γ (PPARγ) is the key decisive factor controlling the development of adipocytes. Ligand-mediated... 
Lipoxygenases | Cyclooxygenases | Reactive oxygen species | Polyunsaturated fatty acids | PPARγ | Adipogenesis | AF-1 ligand-independent activation function | NOS nitric oxide synthase | ADH alcohol dehydrogenase | ELOVL3 elongation of very long chain fatty acids 3 | FFA free fatty acid | DPEP dipeptidase | LNO | RXR retinoic X receptor | PTM post-translational modification | prostaglandin J | NOX4 NADPH oxidase 4 | azPC azelayol phosphatidylcholine | HPETE hydroperoxyeicosatetraenoic acid | GGT gamma-glutamyltransferase | MEF mouse embryonic fibroblast | C/EBP CCAAT/enhancer binding protein | TZD thiazolidinedione | Mo-Co molybdenum cofactor | CBR carbonyl reductase | HPODE hydroperoxyoctadecadienoic acid | AA arachidonic acid | HETE hydroxyeicosatrienoic acid | MAPK mitogen-activated protein kinase | PL phospholipase | pRB retinoblastoma protein | Abbreviations NO nitric oxide | cPLA | PTGR prostaglandin reductase | EET epoxyeicosatrienoic | PPARγ peroxisome proliferator-activated receptor γ | ROS reactive oxygen species | cytosolic PLA | EH epoxide hydrolase | BAT Brown adipose tissue | HODE hydroxyoctdecenonic acid | PTGES prostaglandin E synthase | LOX lipoxygenase | Epac exchange protein directly activated by cAMP | LPA lysophosphatidic acid | ChREBP carbohydrate element binding protein | NR nuclear receptor | LA linoleic acid | XOR xanthine oxidoreductase | CPA cyclic phosphatidic acid | AF-2 ligand-dependent activation function | TX thromboxane | 15-deoxy-Δ | PGDH 15-hydroxyprostaglandin dehydrogenase | PGFS prostaglandin F synthase | KETE ketoeicosatetraenoic acid | SREBP-1c sterol-regulatory element binding protein 1c | eLOX3 epidermis lipoxygenase type 3 | GPC glycerophosphocholine | LBD ligand binding domain | nitrolinoleic acid | PTGIS prostacyclin synthase | ONO | PG prostaglandin | RetSat retinol saturase | dioxide radical | EPA eicosapentaenoic acid | MUFA monounsaturated fatty acid | GPx glutathione peroxidase | LTC4S leukotriene C4 synthase | COX cyclooxygenase | IBMX isobutyl-methylxanthine | peroxynitrite | PPRE peroxisome proliferator response element | HPGD 15-hydroxyprostaglandin dehydrogenase | 15-dPGJ | DHET dihydroxyeicosatrienoic acid | FAS fatty acid synthase | PTGDS prostaglandin D2 synthase | sEH soluble epoxide hydrolase | UCP1 uncoupling protein 1 | CYP cytochrome P450 monooxygenase | WAT white adipose tissue | superoxide | FAD flavin adenine dinucleotide | PUFA polyunsaturated fatty acid | TBXAS thromboxane A synthase | INHIBITS ADIPOCYTE DIFFERENTIATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | DOMINANT-NEGATIVE MUTATIONS | CELL-DERIVED ADIPOCYTES | MITOTIC CLONAL EXPANSION | PROLIFERATOR-ACTIVATED-RECEPTOR | PPAR gamma | WHITE ADIPOSE-TISSUE | NUTRITION & DIETETICS | 3T3-L1 PREADIPOCYTE DIFFERENTIATION | POLYUNSATURATED FATTY-ACIDS | LIGAND-BINDING DOMAIN | PROSTAGLANDIN F-2 ALPHA | PPAR gamma - physiology | Prostaglandins | Animals | Oxidation-Reduction | Humans | Lipid Metabolism | Adipocytes - physiology | Fatty Acids - metabolism
Journal Article
Genomics, ISSN 0888-7543, 01/1992, Volume 13, Issue 2, pp. 447 - 448
A DNA polymorphism has been found in the 3'-untranslated region of the carbonyl reductase gene (CBR). Genotypes of the members of the CEPH pedigrees have been... 
linkage analysis | genes | DNA | chromosome 21 | polymorphism | man | carbonyl reductase (NADPH)
Journal Article
Bioresource Technology, ISSN 0960-8524, 02/2018, Volume 250, pp. 457 - 463
(S)-3-chloro-1-phenyl-1-propanol ((S)-CPPO) is an important chiral intermediate predominantly used in the synthesis of the chiral side chain of (S)-fluoxetine.... 
Carbonyl reductase | Glucose dehydrogenase | (S)-fluoxetine | Bio-production | (S)-3-chloro-1-phenyl-1-propanol | ENERGY & FUELS | REGENERATION | ESCHERICHIA-COLI | E. COLI | ORGANIC SOLVENT SYSTEM | AGRICULTURAL ENGINEERING | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | ALCOHOL-DEHYDROGENASE | BIOREDUCTION | Enzymes | Fluoxetine | Escherichia coli | Glucose | Fermentation | Dextrose | Acetone
Journal Article
Journal Article
Journal Article
Marine Environmental Research, ISSN 0141-1136, 09/2012, Volume 80, pp. 56 - 61
Journal Article
Journal Article